辽宁奥克化学股份有限司 第六届监事会第五次会议决议公告 证券代码：300082 证券简称：奥克股份 公告编号：2023-044 辽宁奥克化学股份有限公司 第六届监事会第五次会议决议公告 本公司及监事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 1 辽宁奥克化学股份有限公司（以下简称"公司"）第六届监事会第五次会议 通知于2023年8月15日以通讯、电子邮件发出，会议于2023年8月25日在江苏奥克 化学有限公司会议室以现场结合通讯表决的方式召开，本次会议应参加表决监事 5人，实际参加表决监事5人。会议由监事会主席仲崇纲先生主持，会议的召集、 召开和表决程序符合法律、法规及《公司章程》的规定。本次会议审议通过了以 下议案： 一、审议通过了《公司2023年半年度报告全文及摘要》； 监事会意见：经审核，监事会认为董事会编制和审核《公司2023年半年度报 告》的程序符合法律、行政法规和中国证监会的规定，报告内容真实、准确、完 整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或重大遗漏。 具体内容请见公司于同日在巨潮资讯网（http//www.cninfo.com.cn）披露的 ...

辽宁奥克化学股份有限公司 2023 年半年度计提资产减值准备的公告 证券代码：300082 证券简称：奥克股份 公告编号：2023-042 辽宁奥克化学股份有限公司 2023年半年度计提资产减值准备的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 为公允反映辽宁奥克化学股份有限公司（以下简称"公司"）资产的价值， 根据企业会计准则的相关规定，公司对各项资产进行清查，对存在减值迹象的资 产进行减值测试。2023年8月25日，公司召开了第六届董事会第七次会议、第六 届监事会第五次会议，审议通过了《关于2023年半年度计提资产减值准备的议 案》，公司拟对2023年半年度合并报表范围内的有关资产计提减值损失，具体情 况如下： 一、2023年半年度计提资产减值准备情况概述 1、本期计提资产减值准备的原因 根据《企业会计准则》及公司会计政策的相关规定，本着谨慎性原则，对公 司及下属子公司2023年半年度各类资产进行了全面清查，对应收款项回收的可 能性，各类存货的可变现净值，固定资产、在建工程、无形资产、长期股权投资 及商誉的可变现性进行了充分的评估和分析。以2023年6月 ...

Financial Performance - The net profit attributable to shareholders of the company decreased by over 50% compared to the same period last year, with the net profit after deducting non-recurring gains and losses being negative[4]. - The company's operating revenue for 2022 was CNY 5,639,151,805.71, a decrease of 16.05% compared to CNY 6,717,428,323.07 in 2021[24]. - The net profit attributable to shareholders for 2022 was CNY 5,595,492.74, down 98.41% from CNY 352,237,905.21 in 2021[24]. - The cash flow from operating activities in 2022 was CNY 305,997,532.78, a decline of 38.41% from CNY 496,827,950.63 in 2021[24]. - The total assets at the end of 2022 were CNY 6,416,452,608.88, a decrease of 5.13% from CNY 6,763,326,789.61 at the end of 2021[24]. - The company reported a basic earnings per share of CNY 0.01 for 2022, down 98.08% from CNY 0.52 in 2021[24]. - The company experienced a significant decline in net profit after deducting non-recurring gains and losses, with a net loss of CNY 27,567,613.53 in 2022 compared to a profit of CNY 337,566,539.11 in 2021, marking a 108.17% decrease[24]. - The revenue from concrete additives was CNY 4,485,435,630.8, a decrease of 18.93% compared to the same period last year, with a gross margin of 2.03%[76]. - The revenue from other industries reached CNY 1,117,361,970, reflecting a slight decrease of 1.44% year-on-year, with a gross margin of 15.12%[76]. Dividend and Profit Distribution - The company plans not to distribute cash dividends, issue bonus shares, or increase capital from the capital reserve for the year 2022[5]. - The company plans to retain all profits for 2022, with no cash dividends, stock bonuses, or capital reserve transfers, due to significant capital expenditure needs and ongoing industrial transformation[191]. - The total distributable profit for the reporting period was 227,387,669.16 CNY[190]. - As of December 31, 2022, the accumulated undistributed profits of the parent company amounted to CNY 227,387,669.16, while the consolidated undistributed profits totaled CNY 634,792,953.21[191]. Risk Management and Compliance - The company is facing risks related to regulatory policies, industry development, and product application areas, which are detailed in the management discussion and analysis section[4]. - The company has a comprehensive risk management strategy in place to address potential challenges in its future development[4]. - The company has established and improved its internal control and risk management systems to enhance risk control capabilities and ensure sustainable business development[193]. - The internal control self-assessment report indicated no significant defects in financial reporting or non-financial reporting[197]. - The company has committed to maintaining compliance with relevant laws and regulations, ensuring the independence of its operations from controlling shareholders[198]. Market and Industry Trends - The construction chemical industry faced challenges, with real estate development investment declining by 10.0% in 2022, impacting demand for the company's products[35]. - The company is focused on high-end technology industrialization, particularly in the production of epoxy derivatives and new energy materials[34]. - The market for polycarboxylic acid superplasticizers is expected to maintain stable growth, with the industry moving towards a healthier and more sustainable direction[36]. - The domestic pharmaceutical excipients market is projected to grow in line with the rapid increase in the pharmaceutical manufacturing industry's output, which has seen a compound annual growth rate of over 20% in the past decade[40]. - The market for non-ionic surfactants is expected to maintain stable growth, driven by the increasing demand for personal care and cleaning products[44]. Research and Development - The company is committed to research and development, allocating a significant portion of its budget to innovate and improve product quality in the chemical sector[106]. - The company has established partnerships with research institutions to enhance the development of green surfactants[52]. - The company completed significant advancements in various R&D projects, including the development of injection-grade PEG300 and narrow-distribution polyoxyethylene[86][88]. - The company aims to enhance its competitiveness in the polyethylene glycol and pharmaceutical fields through new product developments and market expansion strategies[86][88]. - The company is actively pursuing mergers and acquisitions to enhance its competitive edge in the chemical industry[106]. Production and Capacity - The production capacity utilization for high-performance polycarboxylate superplasticizers is at 63%, with a design capacity of 854,000 tons and ongoing projects to add 300,000 tons[52]. - The company has a total of 10,000 tons of medicinal polyethylene glycol with a capacity utilization rate of 113%[52]. - The company has a production capacity of 300,000 tons of epoxy ethane and 1.6 million tons of ethoxylation, with a nationwide sales service network covering over 80% of its customers[59]. - The company is expanding its production capabilities in Hainan and Wuhan, with ongoing projects to increase capacity for various products[52]. Strategic Initiatives - The company plans to enhance product innovation and focus on the development of new energy battery materials and electronic chemicals, aiming for a strong market position in these emerging products[122]. - The company aims to optimize its production capacity and strengthen strategic partnerships in the epoxy supply chain, with plans to expand its coastal and riverside ethoxylation capacity to one million tons[122]. - The company is committed to increasing R&D investment, particularly in the development of green low-carbon products derived from epoxy and carbon dioxide[123]. - The company plans to enhance its digital transformation and smart systems to improve management efficiency and reduce operational costs[123]. - The company is expanding its market presence in Southeast Asia, targeting a 25% market share within the next three years[164]. Governance and Management - The company has established a governance structure consisting of the shareholders' meeting, board of directors, supervisory board, and senior management, ensuring clear responsibilities and coordinated operations[138]. - The board of directors consists of 9 members, including 3 independent directors, complying with legal and regulatory requirements[139]. - The company maintains independence from its controlling shareholder in terms of business, assets, personnel, and finance, ensuring a complete and independent operational capability[143]. - The company has a total of 955 production personnel, 92 sales personnel, 203 technical personnel, 57 financial personnel, and 197 administrative personnel[185]. - The company has implemented a dynamic salary management mechanism to attract and retain talent, with a focus on performance-based compensation[186].

Financial Performance - The company's operating revenue for 2021 was ¥6,717,428,323.07, representing a 17.67% increase compared to ¥5,708,496,215.32 in 2020[21] - The net profit attributable to shareholders for 2021 was ¥352,237,905.21, a decrease of 12.54% from ¥402,726,079.80 in 2020[21] - The net cash flow from operating activities decreased by 20.23% to ¥496,827,950.63 in 2021 from ¥622,849,757.51 in 2020[21] - The total assets at the end of 2021 were ¥6,763,326,789.61, an increase of 24.48% from ¥5,433,135,137.77 at the end of 2020[21] - The net assets attributable to shareholders increased by 5.16% to ¥3,449,480,545.49 at the end of 2021 from ¥3,280,376,280.91 at the end of 2020[21] - The basic earnings per share for 2021 was ¥0.52, down 11.86% from ¥0.59 in 2020[21] - The diluted earnings per share also stood at ¥0.52, reflecting the same decrease of 11.86% from the previous year[21] - The weighted average return on equity decreased by 1.50 percentage points to 10.63% in 2021 from 12.13% in 2020[21] Revenue Breakdown - In 2021, the total operating revenue for the company was approximately CNY 6.99 billion, with quarterly revenues of CNY 1.38 billion, CNY 1.73 billion, CNY 1.87 billion, and CNY 1.73 billion respectively[23] - The net profit attributable to shareholders for the year was approximately CNY 352 million, with quarterly profits of CNY 51.12 million, CNY 32.35 million, CNY 109.88 million, and CNY 158.89 million respectively[23] - The concrete admixture industry generated ¥5,532,793,673.04, accounting for 82.36% of total revenue, with a year-on-year growth of 20.89%[66] - Polyether monomer sales amounted to ¥5,532,793,673.04, with a sales volume increase of 20.19% compared to the previous year[69] Market and Product Development - The company is investing in the production of lithium battery electrolyte solvents, utilizing proprietary technology that is "world-first and internationally leading" for carbon dioxide resource utilization[33] - The domestic market for new energy materials, particularly lithium batteries, saw a significant growth with a 157.5% increase in sales of new energy vehicles in 2021, reaching 3.52 million units[33] - The pharmaceutical excipients industry is entering a stable development phase, with the company positioned as a major supplier to over 400 formulation enterprises in China[34] - The company is expanding its market presence in the pharmaceutical excipients sector, developing high-end injectable and raw material grade products for international markets[34] - The company is focusing on the development of epoxy-derived new energy battery materials and enhancing carbon dioxide resource utilization as part of its strategic goals during the 14th Five-Year Plan[33] Strategic Partnerships and Collaborations - The company has established partnerships with Shenzhen Yanyi New Materials Co., Ltd. to promote collaboration in the lithium battery electrolyte solvent sector[33] - The company has established strategic partnerships with major players like Sinopec and PetroChina, ensuring stable raw material supply[55] - The company established a strategic partnership with the China Daily Chemical Research Institute, achieving industrial production of ethoxylated fatty alcohols, reaching a leading level domestically[61] Research and Development - The company is developing new products and technologies, including proprietary catalysts and synthesis methods, to improve product performance and cost efficiency[45] - The company is focusing on expanding its product range through R&D and industrialization of over 20 new product results, enhancing its technological capabilities[61] - The company aims to increase R&D investment and enhance the integration of production, education, and research to improve technological contribution rates and optimize product structure[118] Environmental and Safety Management - The company has established various environmental protection facilities, including wastewater collection pools and online monitoring systems, which are all operating normally[195] - The company maintains a commitment to environmental standards, with no significant pollution incidents reported during the year[197] - The company has implemented a rainwater and sewage diversion system across its subsidiaries to enhance environmental protection measures[195] - The company is facing safety and environmental risks due to the handling of hazardous chemicals like ethylene and ethylene oxide, and it is investing in safety and environmental management systems[124] Governance and Management - The board of directors consists of 9 members, including 3 independent directors, complying with legal and regulatory requirements[130] - The company has established a fair and transparent performance evaluation and incentive mechanism for directors, supervisors, and senior management[131] - The company actively engages in investor relations management, providing multiple channels for investors to access information and communicate[132] - The company has a complete and independent asset structure, including land, buildings, machinery, trademarks, patents, and proprietary technologies[134] Future Outlook and Strategic Goals - The company aims to achieve high-quality development through a unique organizational structure that emphasizes customer-centricity and resource integration[50] - The company has set a long-term vision for 2035, aligning its development strategy with national planning and market trends[50] - The company is committed to becoming a leading manufacturer of green low-carbon fine chemicals and new materials, aligning with national carbon neutrality goals[120] - The company plans to enhance its market response capabilities and increase the contribution of high-margin products through differentiated marketing strategies[118]

证券代码：300082 证券简称：奥克股份 辽宁奥克化学股份有限公司 投资者关系活动记录表 编号：2023-001 投资者关系活动类别 ☐特定对象调研 ☐分析师会议 ☐媒体采访 业绩说明会 ☐新闻发布会 ☐路演活动 ☐现场参观 ☐其他（请文字说明其他活动内容） 形式 ☐现场 网上 ☐电话会议 参与单位名称及人员姓名 线上参与公司2022年度网上业绩说明会的投资者 时间 2023年05月15日15:30-17:00 地点 价值在线（www.ir-online.cn） | --- | |-------------------------| | 董事长 朱建民 | | 执行总裁 朱宗将 | | 独立董事 熊焰韧 | | 财务总监 刘冬梅 | | 副总裁兼董事会秘书 马帅 | | | | | | | 投资者关系活动主要内容 上市公司接待人员姓名 1.贵公司 第一：2022年报净利润大幅下滑的原因是什么？投资 收益什么时候合算报表呢？ 第二：2023年第一季度亏损很大，之前 几年都是大幅度盈利，公司有什么措施应对挑战亏损风险，有没有考 虑多元化投资产业或者投资小微公司，比如计算机Ai行业，传媒教育 介绍 等低投入高产出 ...

投资者关系活动记录表 编号：2023-001 | 投资者关系活动类别 | ☐特定对象调研 | ☐分析师会议 | | --- | --- | --- | | | ☐媒体采访 | 业绩说明会 | | | ☐新闻发布会 | ☐路演活动 | | | ☐现场参观 | | | | ☐其他（请文字说明其他活动内容） | | | 形式 | ☐现场 网上 | ☐电话会议 | | 参与单位名称及人员姓名 线上参与公司2022年度网上业绩说明会的投资者 | | | | 时间 | 2023年05月15日15:30-17:00 | | | 地点 | 价值在线（www.ir-online.cn） | | | | 董事长 朱建民 执行总裁 朱宗将 | | | 上市公司接待人员姓名 | 独立董事 熊焰韧 | | | | 财务总监 刘冬梅 | | | | 副总裁兼董事会秘书 马帅 | | | | 1.贵公司 第一：2022年报净利润大幅下滑的原因是什么？投资 | | | | 收益什么时候合算报表呢？ 第二：2023年第一季度亏损很大，之前 | | | 投资者关系活动主要内容 | 几年都是大幅度盈利，公司有什么措施应对挑战亏损风险，有没有考 ...

辽宁奥克化学股份有限公司 关于举行2022年度业绩说明会的公告 证券代码：300082 证券简称：奥克股份 公告编号：2023-035 辽宁奥克化学股份有限公司 关于举行2022年度业绩说明会的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 辽宁奥克化学股份有限公司（以下简称"公司"）已于 2023 年 4 月 19 日在巨潮资讯网披露了《2022 年年度报告》。为便于广大投 资者更加全面深入了解公司经营和发展战略等情况，公司定于 2023 年 5 月 15 日（星期一）15:30-17:00 在"价值在线"举行 2022 年度业 绩说明会（以下简称"本次说明会"），与投资者进行沟通交流。 一、说明会召开的时间、地点和方式 会议召开时间：2023 年 05 月 15 日（星期一）15:30-17:00 会议召开地点：价值在线（www.ir-online.cn） 会议召开方式：网络线上互动方式 二、参加人员 出席本次说明会的人员有：公司董事长朱建民先生，独立董事熊 焰韧女士，总裁朱宗将先生，财务总监刘冬梅女士，副总裁兼董事会 秘书马帅先生。 三、投资者参与方式 ...

Financial Performance - The company's revenue for Q1 2023 was ¥937,379,889.10, a decrease of 30.03% compared to ¥1,339,641,333.20 in the same period last year[4] - The net profit attributable to shareholders was -¥60,293,953.02, representing a decline of 160.46% from ¥99,723,888.74 year-on-year[4] - Net profit for the current period is a loss of ¥56,406,385.03, compared to a profit of ¥103,949,302.48 in the previous period, indicating a significant decline[27] - Basic and diluted earnings per share for the current period are both -¥0.09, compared to ¥0.15 in the previous period[27] Cash Flow - The net cash flow from operating activities improved by 60.30%, amounting to -¥61,570,119.46 compared to -¥155,105,627.53 in the previous year[4] - Cash inflow from operating activities totals ¥1,003,309,319.61, down from ¥1,365,138,606.30 in the previous period, representing a decrease of approximately 26.5%[29] - The net cash flow from operating activities was -61,570,119.46 CNY, compared to -155,105,627.53 CNY in the previous year, indicating an improvement[30] - Cash outflow from operating activities totaled 1,064,879,439.07 CNY, compared to 1,520,244,233.83 CNY in the previous year, indicating a reduction[30] Assets and Liabilities - The total assets decreased by 7.79% to ¥5,916,425,677.92 from ¥6,416,452,608.88 at the end of the previous year[4] - The company's current assets decreased to CNY 2,226,595,305.97 from CNY 2,720,910,604.23, reflecting a decline of approximately 18.2%[20] - The total liabilities decreased to CNY 2,264,002,690.44 from CNY 2,708,455,651.15, indicating a decline of around 16.4%[20] - The total liabilities amount to ¥2,477,256,794.06, a decrease from ¥2,922,955,322.58 in the previous period[23] Equity - The company’s weighted average return on equity was -1.87%, down from 2.85% in the previous year[4] - Total equity attributable to shareholders of the parent company is ¥3,187,672,463.47, down from ¥3,246,157,096.43[23] Investment and Expenses - The company reported a decrease in investment income by ¥25,586,300.00, primarily due to reduced earnings from joint ventures[9] - Research and development expenses for the current period are ¥13,322,890.81, slightly down from ¥14,345,737.07 in the previous period[26] - Financial expenses increased to ¥11,302,377.65 from ¥10,418,249.53, marking an increase of about 8.5%[26] Inventory and Receivables - The inventory increased to CNY 416,756,888.94 from CNY 331,577,861.06, representing a growth of about 25.7%[20] - The accounts receivable increased to CNY 326,317,830.53 from CNY 284,121,981.15, reflecting a growth of approximately 14.9%[19] Other Financial Metrics - The gross profit margin dropped by 11.27 percentage points, leading to a gross profit reduction of ¥15,020,480.00[9] - The company experienced a 49.93% increase in contract liabilities, amounting to an increase of ¥29,247,500.00 due to higher prepayments received[8] - The company reported a decrease in other current liabilities by 45.82%, amounting to a reduction of ¥350,990,900.00, mainly due to a decrease in discounted bills[8]

Financial Performance - The net profit attributable to shareholders of the company decreased by over 50% compared to the same period last year, with the net profit after deducting non-recurring gains and losses being negative [4]. - The company's operating revenue for 2022 was CNY 5,639,151,805.71, a decrease of 16.05% compared to CNY 6,717,428,323.07 in 2021 [24]. - The net profit attributable to shareholders was CNY 5,595,492.74, down 98.41% from CNY 352,237,905.21 in the previous year [24]. - The cash flow from operating activities decreased by 38.41% to CNY 305,997,532.78 from CNY 496,827,950.63 in 2021 [24]. - The basic earnings per share dropped to CNY 0.01, a decline of 98.08% from CNY 0.52 in 2021 [24]. - The total assets at the end of 2022 were CNY 6,416,452,608.88, a decrease of 5.13% from CNY 6,763,326,789.61 at the end of 2021 [24]. - The company reported a significant decline in net profit after deducting non-recurring gains and losses, with a loss of CNY 27,567,613.53 compared to a profit of CNY 337,566,539.11 in 2021, marking a 108.17% decrease [24]. - Total revenue for 2022 was approximately ¥5.64 billion, a decrease of 16.05% compared to ¥6.72 billion in 2021 [73]. - The company achieved a net profit of CNY 55,954,492.74 for the year 2022, with the parent company reporting a net profit of CNY 70,934,820.06 [191]. Dividend Policy - The company plans not to distribute cash dividends, issue bonus shares, or increase capital using capital reserves for the fiscal year 2022 [5]. - The company has decided not to distribute cash dividends for the year 2022, citing the need to retain funds for operational stability and industry expansion [191]. - The company distributed a cash dividend of 3.42 RMB per 10 shares, totaling 2,325,935,844.00 RMB, based on a total share capital of 680,098,200 shares [188]. Risk Management - The company is facing risks related to regulatory policies, industry development, and product application areas, with corresponding countermeasures discussed in the report [4]. - The company emphasizes the importance of investors being aware of the risks associated with forward-looking statements regarding future plans [4]. - The company faces risks from raw material price fluctuations, particularly in ethylene and ethylene oxide, and plans to optimize procurement channels to mitigate these risks [128]. - The company is addressing industry capacity risks by accelerating the expansion and upgrading of existing production facilities to focus on differentiated and high-end products [129]. - The company is enhancing its accounts receivable management to mitigate bad debt risks as sales scale increases, aiming to improve the quality of receivables [131]. - The company is implementing a foreign exchange risk management system to mitigate risks associated with currency fluctuations in its international operations [134]. Research and Development - The company has outlined measures to improve profitability in the management discussion and analysis section of the report [4]. - The company is focusing on high-end technology industrialization, particularly in the production of epoxy derivatives and new energy materials [34]. - The company is actively engaged in research and development for new materials and technologies, focusing on lithium battery solutions [106]. - The company plans to enhance its innovation efforts by developing a green low-carbon industrial chain for epoxy derivatives, including the industrialization of carbonate technology and the development of new POD products [124]. - The company aims to increase its investment in research and development, aiming to strengthen the integration of production, education, and research, and enhance the competitiveness of its products [125]. - The company’s R&D expenses increased by 11.43% to 55,753,159.82 CNY in 2022, compared to 50,035,075.62 CNY in 2021 [85]. - The number of R&D personnel increased by 3.57% to 203 in 2022, with a higher proportion of bachelor's degree holders at 58.66% [88]. Market Position and Strategy - The company holds approximately 40% market share in the domestic polycarboxylic acid superplasticizer market, maintaining its leading position [45]. - The expected compound annual growth rate for China's lithium battery market from 2022 to 2030 is projected to be 23.84% [38]. - The company is focusing on developing green low-carbon series products derived from ethylene oxide and carbon dioxide, enhancing its competitive advantage in the market [46]. - The company is positioning itself to become a leading manufacturer of green low-carbon fine chemicals and new materials in China [122]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by the end of 2024 [154]. - A strategic acquisition of a local competitor is anticipated to enhance the company's production capacity by 30% and reduce operational costs by 15% [154]. Governance and Management - The financial report has been confirmed by the board of directors, supervisors, and senior management to be true, accurate, and complete [4]. - The report indicates that all directors attended the board meeting to review the annual report [4]. - The company has established a governance structure consisting of the shareholders' meeting, board of directors, supervisory board, and senior management, ensuring clear responsibilities and coordinated operations [138]. - In 2022, the board of directors completed its sixth election, consisting of 9 members, including 3 independent directors, complying with legal and regulatory requirements [139]. - The company maintains independence from its controlling shareholder in terms of assets, personnel, finance, and operations, ensuring a complete and independent business structure [143]. - The company has an independent financial accounting department and a separate accounting system, allowing for independent financial decision-making [144]. - The management team remains stable, with no new appointments or resignations noted in the report [147]. Environmental and Safety Compliance - The company has received environmental impact approvals for several projects, including a 200,000 tons/year epoxy-derived green energy new material project [53]. - The company holds a pollution discharge permit valid until June 27, 2023 [54]. - The company has a safety production standardization level II certification valid until December 2023 [56]. - The company maintained a zero major safety and environmental incident record in 2022, demonstrating its commitment to safety management [70]. - The company is committed to improving safety and environmental protection by implementing a three-year action plan for safety production and upgrading production processes to reduce hazardous waste emissions [125]. Sales and Revenue Growth - The total sales volume of new material carbonate series products reached 38,900 tons in 2022, representing a year-on-year growth of 45% [66]. - The sales volume of the new product OXAC-609 in the polyether segment reached 129,600 tons, an increase of 174% year-on-year [66]. - The company’s EOD export sales totaled 26,000 tons, a significant increase of 160% compared to the same period last year, with a 168% growth in water-reducing agents [67]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion RMB for the fiscal year 2022, representing a year-over-year growth of 15% [154]. - User data showed an increase in active users, reaching 2 million by the end of 2022, which is a 25% increase compared to the previous year [154]. Investment and Financial Management - The company has ongoing significant non-equity investments, including a project with an expected investment of 6,980 million CNY for a chemical processing facility [107]. - The company has pledged a total of 484.08 million CNY as collateral for bill pledges, indicating a strong reliance on bank financing [102]. - The company’s financial liabilities remained at 0.00 CNY, indicating no outstanding debts at the end of the reporting period [100]. - The company provided a total of 11,093.36 million CNY as guarantee deposits for various banking instruments, including bank acceptance bills and letters of credit [102]. - The company reported a total of 395,814,497.16 CNY in financial assets at the end of the reporting period, with a fair value change of 2,923,907 CNY [100].

Group 1: Company Strategy and Development - The company focuses on "epoxy-based value creation" as its core development strategy and has implemented its 2014 production and operation plan [2] - The company has established production bases in Northeast, North China, Central China, and South China, completing a national strategic layout along coastal and river areas [2][3] - The company aims to enhance its supply chain system, optimize product structure, innovate profit models, and improve profitability [3] Group 2: Project Construction and Progress - Key projects for 2014 include the Yangzhou Ethylene Oxide project and the associated low-temperature ethylene storage tank project, with the latter already operational since October [3] - The Yangzhou Ethylene Oxide project is the company's first upstream extension, expected to alleviate resource bottlenecks and create a new development model [3] - The Wuhan project is positioned as a significant production base in Central China, leveraging resource advantages and geographical location for strategic development [3] Group 3: Financial Performance and Market Trends - In the first three quarters of 2014, the company sold over 150,000 tons of polycarboxylate superplasticizers, generating over 1.6 billion yuan in revenue [3] - The cutting fluid products sold over 30,000 tons, achieving nearly 400 million yuan in revenue [3] - Demand for polycarboxylate superplasticizers is expected to grow due to national infrastructure policies and technological advancements [4] Group 4: Corporate Governance and Compliance - The company adheres to legal regulations and its investor relations management system, ensuring the authenticity, accuracy, completeness, timeliness, and fairness of information disclosure [4] - No significant undisclosed information leakage occurred during the investor communication process [4]